These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17019081)

  • 1. Secondary anetoderma associated with mastocytosis.
    Kalogeromitros D; Gregoriou S; Makris M; Georgala S; Kempuraj D; Theoharides TC
    Int Arch Allergy Immunol; 2007; 142(1):86-8. PubMed ID: 17019081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coexistence of pigmented urticaria and mastocytomas: a case report].
    Filipowska B; Gebska E; Pindycka-Piaszczyńska M; Sabat D; Zajecki W
    Pol Merkur Lekarski; 2003 May; 14(83):441-3. PubMed ID: 12939822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
    Hollmann TJ; Brenn T; Hornick JL
    Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basophil/mast cell precursors in mast cell proliferative disorders.
    Denburg JA; Telizyn S; Ahlstedt S; Olafsson JH; Roupe G; Bienenstock J
    Clin Invest Med; 1986; 9(1):21-5. PubMed ID: 3955917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mastocytosis with urticaria pigmentosa and osteoporosis.
    Stein JA; Kamino H; Walters RF; Pomeranz MK
    Dermatol Online J; 2008 Oct; 14(10):2. PubMed ID: 19061601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous and systemic manifestations of mastocytosis.
    Alto WA; Clarcq L
    Am Fam Physician; 1999 Jun; 59(11):3047-54, 3059-60. PubMed ID: 10392589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistence of two types of clinical lesions in childhood-onset mastocytosis.
    Pérez-Pérez L; Allegue F; Caeiro JL; Fabeiro JM; Pérez Rodríguez A; Zulaica A
    Indian J Dermatol Venereol Leprol; 2011; 77(2):184-7. PubMed ID: 21393950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mastocytosis evolving into anetoderma. Review of the literature (author's transl)].
    Thivolet J; Cambazard F; Souteyrand P; Pierini AM
    Ann Dermatol Venereol; 1981; 108(3):259-66. PubMed ID: 7020556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal mastocytosis with pachydermic bullous skin without c-Kit 816 mutation.
    Walker T; von Komorowski G; Scheurlen W; Dorn-Beineke A; Back W; Bayerl C
    Dermatology; 2006; 212(1):70-2. PubMed ID: 16319478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
    Florian S; Krauth MT; Simonitsch-Klupp I; Sperr WR; Fritsche-Polanz R; Sonneck K; Födinger M; Agis H; Böhm A; Wimazal F; Horny HP; Valent P
    Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anetodermic mycosis fungoides: a new clinicopathological variant of mycosis fungoides.
    Requena L; González-Guerra E; Angulo J; DeVore AE; Sangueza OP
    Br J Dermatol; 2008 Jan; 158(1):157-62. PubMed ID: 17999702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.
    Ridell B; Olafsson JH; Roupe G; Swolin B; Granerus G; Rödjer S; Enerbäck L
    Arch Dermatol; 1986 Apr; 122(4):422-7. PubMed ID: 3954410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.
    van Doormaal JJ; van der Veer E; van Voorst Vader PC; Kluin PM; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; Oude Elberink JN; de Monchy JG
    Allergy; 2012 May; 67(5):683-90. PubMed ID: 22435702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual cutaneous findings of urticaria pigmentosa and telangiectasia macularis eruptiva perstans associated with marked myelofibrosis.
    Turchin I; Barankin B; Schloss E
    Int J Dermatol; 2006 Oct; 45(10):1215-7. PubMed ID: 17040445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urticaria pigmentosa associated with anetoderma.
    Carr RD
    Acta Derm Venereol; 1971; 51(2):120-2. PubMed ID: 4101042
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous mastocytosis in Thai children.
    Singalavanija S; Limpongsanurak W
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S143-6. PubMed ID: 19253510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sudden death in the presence of systemic mastocytosis and urticaria pigmentosa].
    Wehner F; Wehner HD; Fritz P; Benz D; Schulz MM
    Arch Kriminol; 2008; 222(5-6):187-94. PubMed ID: 19216369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous and systemic mastocytosis in adults. A clinical, histopathological and immunological evaluation in relation to histamine metabolism.
    Olafsson JH
    Acta Derm Venereol Suppl (Stockh); 1985; 115():1-43. PubMed ID: 3901645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Xanthogranuloma and cutaneous mastocytosis in adults].
    Benzerara N; Combemale P; Abitan R; Kanitakis J; Guennoc B; Chouvet B
    Ann Dermatol Venereol; 1994; 121(6-7):489-92. PubMed ID: 7702283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.